Clinical and treatment-related factors associated with poorer outcomes in Clostridioides difficile infection (CDI) have been identified, particularly among critically ill and immunocompromised patients.
Follow Hospitalpharmacyeuropefeed's news and updates in a matter of seconds! We will deliver any update via email, phone or you can read them from here on the site on your own news page.
You can even combine different feeds with the feed for Hospitalpharmacyeuropefeed.
Subscribing and unsubscribing is fast, easy and risk free.
The whole service is free of cost.
Hospitalpharmacyeuropefeed: Hospital Pharmacy Europe - Clinical News, Views & ResearchHospital Pharmacy Europe